Aeglea BioTherapeutics to Present at BMO Capital Markets 2018 Prescription for Success Healthcare Conference

World News: . []

AUSTIN Texas Dec 06 2018 GLOBE NEWSWIRE -- Aeglea BioTherapeutics Inc NASDAQ AGLE a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer, will p...

More news and information about Aeglea BioTherapeutics, Inc.

Published By:

Globe Newswire: 21:05 GMT Thursday 6th December 2018

Published: .

Search for other references to "aeglea" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us